- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Potentially Undervalued Companies
Swedish Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED May 19, 2022
Companies with a Value score of at least 3, ordered by Value score
14 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| COMBICombiGene | kr8.05 | 6.6% | 5.9% | kr159.4m | n/a | PS5.5x | n/a | n/a | ||
| KDEVKarolinska Development | kr2.72 | 7.1% | 72.6% | kr733.9m | kr5.40 | PS4.4x | E-144.0% | n/a | ||
| PFEPfizer | kr516.50 | 2.9% | 54.3% | kr284.2b | kr589.29 | PS11.2x | E-17.1% | 3.2% | ||
| EGTX BTAEgetis Therapeutics | kr3.85 | n/a | n/a | kr858.4m | kr8.66 | PS20.7x | E131.6% | n/a | ||
| ORXOrexo | kr19.76 | 4.0% | -50.5% | kr678.3m | kr33.50 | PS1.1x | E64.2% | n/a | ||
| EGTXEgetis Therapeutics | kr4.00 | 5.4% | -33.4% | kr858.4m | kr9.00 | PS20.7x | E131.6% | n/a | ||
| MCAPMedCap | kr175.00 | 0.7% | -16.3% | kr2.6b | n/a | PS25.5x | n/a | n/a | ||
| IMMUImmunicum | kr2.35 | 23.0% | -53.4% | kr468.6m | kr8.00 | PS282.1x | S176.7% | n/a | ||
| SENZASenzaGen | kr9.52 | 1.3% | -30.5% | kr229.1m | kr16.00 | PS14.9x | E52.0% | n/a | ||
| ATORXAlligator Bioscience | kr1.57 | -10.5% | -72.5% | kr346.9m | kr3.63 | PS19.2x | E66.4% | n/a | ||
| SOBISwedish Orphan Biovitrum | kr213.20 | 1.2% | 44.2% | kr62.9b | kr245.88 | PS24.9x | E21.6% | n/a | ||
| BINVBioInvent International | kr44.30 | 5.4% | -13.7% | kr2.6b | kr99.50 | PS86.8x | E85.7% | n/a | ||
| GUARDGuard Therapeutics International | kr1.06 | 3.3% | -25.7% | kr363.0m | kr2.00 | PB2.3x | E85.8% | n/a | ||
| XSPRAYXspray Pharma | kr61.20 | -1.3% | -29.6% | kr1.3b | kr116.00 | PB2.2x | E98.5% | n/a |
Page 1 of 1